World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
55
Citations
11550
World Ranking
3800
National Ranking
157

Research.com Recognitions

  • 2013 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

David Ritchie is affiliated with the Peter MacCallum Cancer Centre in Australia and has extensively contributed to the fields of medicine, particularly focusing on hematology and oncology. With a publication record concentrated in hematology, oncology, genetics, pathology and forensic medicine, and immunology, their research covers a broad spectrum within medical sciences.

The main topics of David Ritchie's work include:

  • Hematopoietic Stem Cell Transplantation
  • Lymphoma Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • CAR-T Cell Therapy Research
  • Chronic Myeloid Leukemia Treatments
  • Acute Lymphoblastic Leukemia Research

Frequent publication venues for Ritchie's work include:

  • Blood
  • Internal Medicine Journal
  • Bone Marrow Transplantation
  • Leukemia & Lymphoma / Leukemia and Lymphoma
  • Transplantation and Cellular Therapy

Notable recent papers authored or co-authored by David Ritchie are:

  • Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance, 2020, The Medical Journal of Australia
  • Value and affordability of CAR T-cell therapy in the United States, 2020, Bone Marrow Transplantation
  • Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II), 2021, JAMA Oncology
  • T Cell Fitness and Autologous CAR T Cell Therapy in Haematologic Malignancy, 2021, Frontiers in Immunology
  • Pretransplant FLT3-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome, 2022, Blood

Collaborations have been an essential part of Ritchie's scientific activity, frequently co-authoring with:

  • Rachel Koldej
  • Ashish Bajel
  • Piers Blombery
  • Travis Perera
  • Constantine S. Tam

David Ritchie was recognized as a Fellow of the American Association for the Advancement of Science (AAAS) in 2013, acknowledging their contributions to scientific research and advancement.

Best Publications

  • Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma

    H Quach;D Ritchie;D Ritchie;A K Stewart;P Neeson

  • The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions

    Christopher J Chan;Ludovic Martinet;Susan Gilfillan;Fernando Souza-Fonseca-Guimaraes

  • Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemia.

    David S. Ritchie;Paul J. Neeson;Paul J. Neeson;Amit Khot;Stefan Peinert

  • Late Ebola virus relapse causing meningoencephalitis: a case report.

    Michael Jacobs;Alison Rodger;David J Bell;Sanjay Bhagani

  • Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity.

    A J Davenport;R S Cross;R S Cross;K A Watson;Y Liao

  • CD8+ T Cell-Dependent Elimination of Dendritic Cells In Vivo Limits the Induction of Antitumor Immunity

    Ian F. Hermans;David S. Ritchie;Jianping Yang;Joanna M. Roberts

  • Human blood MAIT cell subsets defined using MR1 tetramers.

    Nicholas A. Gherardin;Michael N.T. Souter;Hui Fern Koay;Kirstie M. Mangas

  • Lack of durable disease control with chemotherapy for mycosis fungoides and Sézary syndrome: a comparative study of systemic therapy

    Charlotte F. M. Hughes;Charlotte F. M. Hughes;Amit Khot;Christopher McCormack;Christopher McCormack;Stephen Lade

  • Autoimmunity associated with immunotherapy of cancer.

    Sally M. Amos;Connie P. M. Duong;Jennifer A. Westwood;David S. Ritchie

  • The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy

    Andy K. Hsu;Hang Quach;Hang Quach;Tsin Tai;H. Miles Prince;H. Miles Prince

  • Diversity of T Cells Restricted by the MHC Class I-Related Molecule MR1 Facilitates Differential Antigen Recognition

    Nicholas A. Gherardin;Nicholas A. Gherardin;Andrew N. Keller;Rachel E. Woolley;Jérôme Le Nours

  • Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells

    Saar Gill;Adrianne E. Vasey;Alysha De Souza;Jeanette Baker

  • Immunosurveillance and therapy of multiple myeloma are CD226 dependent

    Camille Guillerey;Camille Guillerey;Lucas Ferrari de Andrade;Lucas Ferrari de Andrade;Slavica Vuckovic;Kim Miles

  • A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma.

    Chanyoon Cheah;Kirsten Herbert;Kacey M O'Rourke;Glen A Kennedy

  • Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network

    C. Y. Cheah;C. Y. Cheah;A. George;E. Gine;A. Chiappella

  • Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen

    S Peinert;H M Prince;H M Prince;P M Guru;M H Kershaw

  • Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance.

    Robert Weinkove;Robert Weinkove;Zoe K McQuilten;Jonathan Adler;Meera R Agar

  • CAR-T cells inflict sequential killing of multiple tumor target cells

    Alexander J Davenport;Alexander J Davenport;Misty R Jenkins;Ryan Stanley Cross;Carmen S. Yong

  • A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemia

    Simon Z He;Samantha Busfield;David S Ritchie;Mark S Hertzberg

  • Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy.

    D A Carney;D A Westerman;D A Westerman;C S Tam;A Milner

  • The BTK Inhibitor, Bgb-3111, Is Safe, Tolerable, and Highly Active in Patients with Relapsed/ Refractory B-Cell Malignancies: Initial Report of a Phase 1 First-in-Human Trial

    Constantine Tam;Constantine Tam;Andrew P Grigg;Stephen Opat;Matthew Ku

Frequent Co-Authors

John F. Seymour
John F. Seymour Peter MacCallum Cancer Centre
Jeff Szer
Jeff Szer Peter MacCallum Cancer Centre
Constantine S. Tam
Constantine S. Tam University of Melbourne
H. Miles Prince
H. Miles Prince Peter MacCallum Cancer Centre
Andrew Grigg
Andrew Grigg Austin Hospital
Andrew W. Roberts
Andrew W. Roberts Walter and Eliza Hall Institute of Medical Research
Mark J. Smyth
Mark J. Smyth QIMR Berghofer Medical Research Institute
Monica A. Slavin
Monica A. Slavin Peter MacCallum Cancer Centre
Joseph A. Trapani
Joseph A. Trapani Peter MacCallum Cancer Centre
Phillip K. Darcy
Phillip K. Darcy Peter MacCallum Cancer Centre

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology opens doors to various healthcare professions that often require specialized education. For those interested in nursing, exploring lpn programs easy to get into can be a great starting point. These programs provide foundational clinical skills and can lead to further advancement in the medical field.

Many students opt for flexibility through online education, making easiest online nurse practitioner programs a popular choice. These programs allow for convenient study schedules while preparing students for advanced practice roles.

For those interested in mental health, specializing as a psychiatric mental health nurse practitioner is highly rewarding. Finding the best online psychiatric mental health nurse practitioner programs is key to gaining quality clinical experience and maximizing career opportunities.

Cost is also an important consideration. Prospective students should review options like affordable pmhnp programs to balance financial investment with educational quality.

Overall, these pathways provide valuable routes for those passionate about immunology and healthcare, combining practical skills with specialized knowledge to contribute effectively in diverse medical settings.

Best Scientists Citing David Ritchie

Trending Scientists

Recently Published Articles